T98g Cells Treated With 100 Gml Of Fm And Then Secondarily Exposed To

T98G cells treated with 100 μg/mL of FM and then secondarily exposed to ...
T98G cells treated with 100 μg/mL of FM and then secondarily exposed to ...
T98G cells treated with 100 μg/mL of FM and then secondarily exposed to ...
T98G cells treated with 100 μg/mL of FM and then secondarily exposed to ...
(A) LN229 and T98G cells were treated with 100 µM or 200 µM of TMZ or ...
(A) LN229 and T98G cells were treated with 100 µM or 200 µM of TMZ or ...
LN229 and T98G cells were treated with 100 or 200 µM of TMZ or TMZ-Se ...
LN229 and T98G cells were treated with 100 or 200 µM of TMZ or TMZ-Se ...
Colony formation abilities of T98G and Hs683 cells treated with CVB-D ...
Colony formation abilities of T98G and Hs683 cells treated with CVB-D ...
(A and B) Cell divisions of T98G cells exposed to TMZ, DXM and ...
(A and B) Cell divisions of T98G cells exposed to TMZ, DXM and ...
Influence of ECM proteins on the sensitivity of T98G and PC3 cells to ...
Influence of ECM proteins on the sensitivity of T98G and PC3 cells to ...
IKK is activated in response to pIC. (A) T98G cells were treated with ...
IKK is activated in response to pIC. (A) T98G cells were treated with ...
Cytopathology of T98G cells exposed to vehicle or 17α-AED (10 μM) for ...
Cytopathology of T98G cells exposed to vehicle or 17α-AED (10 μM) for ...
(A) T98G, LN229, 1205LU and UACC903 cells were treated with 100 µM or ...
(A) T98G, LN229, 1205LU and UACC903 cells were treated with 100 µM or ...
(A) Among T98G and LN18 cells treated for 36 hours with PBS, TMZ (200 ...
(A) Among T98G and LN18 cells treated for 36 hours with PBS, TMZ (200 ...
Treatment of A172 and T98G cells with TMZ-loaded MO nanoparticles ...
Treatment of A172 and T98G cells with TMZ-loaded MO nanoparticles ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
T98G human glioblastoma cells visualized by TEM. Cells were exposed to ...
T98G human glioblastoma cells visualized by TEM. Cells were exposed to ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
Morphology of compound 2 treated T98G brain cancer cells at 24 h after ...
Effect of helichrysetin and TNF-α on apoptosis. HeLa and T98G cells ...
Effect of helichrysetin and TNF-α on apoptosis. HeLa and T98G cells ...
Cellular shapes of T98G and U-87 MG cells. (A) U-87 MG cells and T98G ...
Cellular shapes of T98G and U-87 MG cells. (A) U-87 MG cells and T98G ...
Cells proliferation of CM-treated T98G cells compared to control cells ...
Cells proliferation of CM-treated T98G cells compared to control cells ...
Cells proliferation of CM-treated T98G cells compared to control cells ...
Cells proliferation of CM-treated T98G cells compared to control cells ...
(A) Cell viability of T98G, LN428, and A375 cells transfected with ...
(A) Cell viability of T98G, LN428, and A375 cells transfected with ...
T98G, U118MG, U251MG and U87MG cells were treated with TMZ [100μM] for ...
T98G, U118MG, U251MG and U87MG cells were treated with TMZ [100μM] for ...
G6 reduces migratory and invasive potential of T98G cells. A) Cells ...
G6 reduces migratory and invasive potential of T98G cells. A) Cells ...
Assessment of morphological features of apoptosis in C6 and T98G cells ...
Assessment of morphological features of apoptosis in C6 and T98G cells ...
Viability of the cell lines HA and T98G after 48 h of treatment with an ...
Viability of the cell lines HA and T98G after 48 h of treatment with an ...
Effect of C/EBPβ and S100A4 on T98G cells motility. TC and TI cells ...
Effect of C/EBPβ and S100A4 on T98G cells motility. TC and TI cells ...
Effect of C/EBPβ and S100A4 on T98G cells invasion capacity. (A ...
Effect of C/EBPβ and S100A4 on T98G cells invasion capacity. (A ...
Number of U87MG and T98G cells that migrated through the membrane ...
Number of U87MG and T98G cells that migrated through the membrane ...
Induction of differentiation in proteins in C6 and T98G cells after the ...
Induction of differentiation in proteins in C6 and T98G cells after the ...
Cell susceptibility to SR9009 treatment in cultures of T98G (a) and ...
Cell susceptibility to SR9009 treatment in cultures of T98G (a) and ...
The viability of DASC (A-C), T98G (D-F) and LN-18 (G-I) cells after ...
The viability of DASC (A-C), T98G (D-F) and LN-18 (G-I) cells after ...
Luteolin inhibited migration and invasion of U-87 MG and T98G cells ...
Luteolin inhibited migration and invasion of U-87 MG and T98G cells ...
A. The images after actin staining of control and FL dyed T98G cell ...
A. The images after actin staining of control and FL dyed T98G cell ...
(A) Increase in apoptotic T98G glioma cells after treatment with CORL ...
(A) Increase in apoptotic T98G glioma cells after treatment with CORL ...
Protein expression in T98G cells by immunocytochemistry and SR9009 ...
Protein expression in T98G cells by immunocytochemistry and SR9009 ...
Changes in cell viability in rat C6 and human T98G glioblastoma cells ...
Changes in cell viability in rat C6 and human T98G glioblastoma cells ...

Loading image details...

Source
Dimensions